Stoke Therapeutics Inc. (STOK)
NASDAQ: STOK
· Real-Time Price · USD
17.95
0.78 (4.54%)
At close: Aug 15, 2025, 2:50 PM
Stoke Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 199.89M | 190.91M | 36.55M | 16.74M | 15.16M | 7.84M | 8.78M | 9.25M | 8.85M | 14.56M | 12.4M | 9.14M | 6.23M | 3M | n/a | n/a | n/a | n/a |
Cost of Revenue | 3.29M | 4.41M | 4.44M | 4.55M | 4.64M | 4.7M | 4.73M | 4.67M | 4.39M | 4.06M | 3.54M | 3M | 2.66M | 2.35M | 2.23M | 1.61M | 1.03M | 507K |
Gross Profit | 186.08M | 189.8M | 34.33M | 13.3M | 10.52M | 3.15M | 4.05M | 4.58M | 4.46M | 10.5M | 8.87M | 6.13M | 3.58M | 653K | -2.23M | -1.61M | -1.03M | -507K |
Operating Income | 40.28M | 38.24M | -101.37M | -117.3M | -114.53M | -118.45M | -110.52M | -108.11M | -108.03M | -100M | -104.36M | -101.71M | -97.24M | -94.03M | -86.06M | -76.13M | -67.15M | -58.14M |
Interest Income | 9.4M | 13.1M | 12.64M | 12.25M | 11.36M | 10.23M | 9.91M | 8.8M | 7.14M | 5.12M | 3.02M | 1.57M | 580K | 70K | 88K | 62K | 73K | 89K |
Pretax Income | 53.76M | 51.55M | -88.98M | -105.46M | -103.57M | -108.53M | -104.7M | -103.4M | -104.97M | -98.96M | -101.07M | -99.86M | -96.35M | -93.66M | -85.81M | -75.92M | -67M | -58M |
Net Income | 52.48M | 50.27M | -88.98M | -105.46M | -103.57M | -108.53M | -100.45M | -95.54M | -95.08M | -87.64M | -93.75M | -96.15M | -94.66M | -93.41M | -85.81M | -75.92M | -67M | -58M |
Selling & General & Admin | 55.45M | 52.66M | 47.68M | 44.86M | 42.44M | 40.19M | 40.73M | 40.09M | 39.77M | 39.65M | 38.92M | 38.27M | 36.65M | 34.47M | 31.9M | 28.86M | 26.13M | 23.24M |
Research & Development | 104.16M | 98.89M | 88.02M | 85.75M | 83.82M | 83.78M | 81.61M | 81.51M | 81.35M | 79.16M | 77.84M | 72.58M | 66.83M | 62.56M | 54.17M | 47.27M | 41.02M | 34.89M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | 41K | 83K | 124K | 166K | 167K | 167K | 168K | 168K | 154K | 128K | 101K | 75K | 50K |
Operating Expenses | 159.61M | 151.56M | 135.7M | 130.61M | 126.25M | 123.97M | 122.34M | 121.61M | 121.12M | 118.81M | 116.76M | 110.84M | 103.47M | 97.03M | 86.06M | 76.13M | 67.15M | 58.14M |
Interest Expense | 3.79M | n/a | n/a | n/a | n/a | 2.57M | 4.67M | 6.15M | 7.14M | 4.58M | 2.58M | 1.1M | 148K | 148K | 56K | 56K | 24K | 35K |
Selling & Marketing Expenses | n/a | -562K | -1.11M | -1.7M | -1.7M | -1.14M | -591K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 118.49M | 152.67M | 137.93M | 134.05M | 129.69M | 126.3M | 123.55M | 121.61M | 121.12M | 118.81M | 116.76M | 110.84M | 103.47M | 97.03M | 86.06M | 76.13M | 67.15M | 58.14M |
Income Tax Expense | 1.28M | 1.28M | n/a | n/a | n/a | n/a | -4.25M | -7.86M | -9.89M | -11.32M | -7.32M | -3.79M | -1.8M | -406K | -156K | -88K | -44K | -60K |
Shares Outstanding (Basic) | 58.35M | 57.86M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M | 36.64M |
Shares Outstanding (Diluted) | 58.35M | 59.4M | 57.03M | 56.34M | 55.77M | 46.25M | 44.96M | 44.27M | 44.19M | 42.54M | 39.43M | 39.42M | 39.26M | 37.45M | 36.84M | 36.76M | 36.71M | 36.64M |
EPS (Basic) | 0.90 | 0.84 | -1.68 | -2.1 | -2.18 | -2.41 | -2.27 | -2.23 | -2.29 | -2.19 | -2.41 | -2.51 | -2.51 | -2.52 | -2.33 | -2.11 | -1.91 | -1.7 |
EPS (Diluted) | 0.85 | 0.79 | -1.68 | -2.1 | -2.18 | -2.41 | -2.27 | -2.23 | -2.29 | -2.19 | -2.41 | -2.51 | -2.51 | -2.52 | -2.33 | -2.11 | -1.91 | -1.7 |
EBITDA | 41.83M | 40.33M | -99.19M | -115.03M | -112.16M | -116.02M | -112.3M | -109.91M | -110.07M | -102.36M | -102.81M | -100.53M | -96.2M | -93.05M | -85.09M | -75.15M | -66.2M | -57.2M |
EBIT | 67.58M | 38.24M | -101.37M | -117.3M | -114.53M | -118.45M | -114.77M | -112.36M | -112.28M | -104.25M | -104.36M | -101.71M | -97.24M | -94.03M | -86.06M | -76.13M | -67.15M | -58.14M |
Depreciation & Amortization | 1.54M | 2.09M | 2.18M | 2.27M | 2.37M | 2.99M | 3.58M | 4.1M | 4.39M | 4.06M | 3.54M | 3M | 2.66M | 2.35M | 2.23M | 1.85M | 1.5M | 1.2M |